Reply to Shah, J.S.; Ramasamy, R. Target Antigens in Western and Line Immunoblots for Supporting the Diagnosis of Lyme Disease. Comment on “Porwancher et al. Immunoblot Criteria for Diagnosis of Lyme Disease: A Comparison of CDC Criteria to Alternative Interpretive Approaches. <i>Pathogens</i> 2023, <i>12</i>, 1282”

Documenti analoghi

• Serological diagnosis of toxoplasmosis: evaluation of the commercial test recomLine Toxoplasma IgG immunoblot (Mikrogen) based on recombinant antigens
  di: Jean-Pierre Vincent, et al.
  Pubblicazione: (2022-01-01)
• Determination of Seroprevalence of Borrelia burgdorferi IgG in Adult Population Living in Trabzon
  di: Merve Cora, et al.
  Pubblicazione: (2017-02-01)
• Lyme borreliosis testing - comparison of five ELISA tests against Western blot
  di: Øystein Brorson, et al.
  Pubblicazione: (2009-12-01)
• Increasing of informational content of serological diagnosis of acute Lyme- borreliosis
  di: M.I. Shkilna, et al.
  Pubblicazione: (2020-02-01)
• CRITERIA OF POSITIVITY FOR Ig ANTIBODIES IN THE METHOD OF IMMUNE BLOTTING OF LYME DISEASE
  di: V G Barskova, et al.
  Pubblicazione: (2001-10-01)